Michael Barbella, Managing Editor08.16.22
ZAP Surgical Systems Inc. has bolstered its management team by appointing Foxconn Technology Co. Ltd. Chairman Lu Jun-Fu (Stanley Lu) to its Board of Directors.
“I am thrilled to welcome Stanley Lu to our Board of Directors, where he will join us in our common quest to treat and transform the lives of millions of patients each year by means of the ZAP-X surgical robot,” said Dr. John R. Adler, M.D., Stanford professor of Neurosurgery and founder and CEO of ZAP Surgical Systems. “At ZAP we have developed a platform for non-invasively treating brain cancer. More than 4 million people each year suffer from brain, head and neck cancers and are not being treated optimally with existing radiosurgical solutions. ZAP’s singular goal is to meet this challenge.”
Lu was elected chairman of Foxconn Technology in October 2021. He earned an EMBA from the Chinese University of Hong Kong and an EMBA from the National Sun Yat-sen University. Prior, Lu was chief financial officer and spokesperson of Foxsemicon Integrated Technology Inc.
Terry Guo, founder and former chairman and CEO of Foxconn, co-founded ZAP Surgical in 2014, and contributed entrepreneurial expertise and his anchor investment established ZAP Surgical as an independent company. Prior to the company’s inception, the ZAP-X platform was developed within and spun out from Varian Medical Systems, now a Siemens Healthineers company.
In addition to Foxconn and Siemens Healthineers, ZAP investors include Primavera Capital Group, Chow Tai Fook Enterprises, GT Healthcare Capital Partners, ShangBay Capital, and Hogy Medical.
ZAP Surgical Systems Inc. designs and manufactures the ZAP-X Gyroscopic Radiosurgery platform. ZAP was founded in 2014 by Dr. John R. Adler. In addition to being CEO of ZAP, Adler is Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Adler is also renowned as the inventor of the CyberKnife system and founder of Accuray Inc. The ZAP-X platform incorporates a vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60.
“I am thrilled to welcome Stanley Lu to our Board of Directors, where he will join us in our common quest to treat and transform the lives of millions of patients each year by means of the ZAP-X surgical robot,” said Dr. John R. Adler, M.D., Stanford professor of Neurosurgery and founder and CEO of ZAP Surgical Systems. “At ZAP we have developed a platform for non-invasively treating brain cancer. More than 4 million people each year suffer from brain, head and neck cancers and are not being treated optimally with existing radiosurgical solutions. ZAP’s singular goal is to meet this challenge.”
Lu was elected chairman of Foxconn Technology in October 2021. He earned an EMBA from the Chinese University of Hong Kong and an EMBA from the National Sun Yat-sen University. Prior, Lu was chief financial officer and spokesperson of Foxsemicon Integrated Technology Inc.
Terry Guo, founder and former chairman and CEO of Foxconn, co-founded ZAP Surgical in 2014, and contributed entrepreneurial expertise and his anchor investment established ZAP Surgical as an independent company. Prior to the company’s inception, the ZAP-X platform was developed within and spun out from Varian Medical Systems, now a Siemens Healthineers company.
In addition to Foxconn and Siemens Healthineers, ZAP investors include Primavera Capital Group, Chow Tai Fook Enterprises, GT Healthcare Capital Partners, ShangBay Capital, and Hogy Medical.
ZAP Surgical Systems Inc. designs and manufactures the ZAP-X Gyroscopic Radiosurgery platform. ZAP was founded in 2014 by Dr. John R. Adler. In addition to being CEO of ZAP, Adler is Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Adler is also renowned as the inventor of the CyberKnife system and founder of Accuray Inc. The ZAP-X platform incorporates a vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60.